• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用多参数流式细胞术分析检测亚二倍体:多发性骨髓瘤的一个预后指标。

Detection of hypodiploidy using multi-parameter flow cytometric analysis: a prognostic indicator in multiple myeloma.

作者信息

Morgan R J, Gonchoroff N J, Katzmann J A, Witzig T E, Kyle R A, Greipp P R

机构信息

Mayo Graduate School of Medicine, Rochester, Minnesota 55905.

出版信息

Am J Hematol. 1989 Apr;30(4):195-200. doi: 10.1002/ajh.2830300402.

DOI:10.1002/ajh.2830300402
PMID:2929579
Abstract

We analyzed 49 patients with multiple myeloma (MM) using propidium iodide (PI) staining and flow cytometry to assess DNA content of MM cells in bone marrow. In 12 patients the presence or absence of DNA content aneuploidy could not be determined by analysis of single-parameter DNA histograms alone. Using forward light scatter measurement, resolution of ploidy was readily obtained in all but three cases. Assuming the DNA content of the low light scatter population to be diploid, we were able to classify 7 cases as hypodiploid and 39 as hyperdiploid or diploid. Hyperdiploid or diploid patients survived a median of 24 months and hypodiploid patients only 2.5 months. We conclude that multiparameter analysis of DNA content and light scatter provides easier analysis for the presence or absence of aneuploidy. Patients with DNA content hypodiploidy have a short survival.

摘要

我们使用碘化丙啶(PI)染色和流式细胞术分析了49例多发性骨髓瘤(MM)患者,以评估骨髓中MM细胞的DNA含量。在12例患者中,仅通过单参数DNA直方图分析无法确定DNA含量非整倍体的存在与否。使用前向光散射测量,除3例病例外,在所有病例中都很容易获得倍性分辨率。假设低光散射群体的DNA含量为二倍体,我们能够将7例分类为亚二倍体,39例分类为超二倍体或二倍体。超二倍体或二倍体患者的中位生存期为24个月,而亚二倍体患者仅为2.5个月。我们得出结论,对DNA含量和光散射进行多参数分析可为非整倍体的存在与否提供更简便的分析。DNA含量为亚二倍体的患者生存期较短。

相似文献

1
Detection of hypodiploidy using multi-parameter flow cytometric analysis: a prognostic indicator in multiple myeloma.使用多参数流式细胞术分析检测亚二倍体:多发性骨髓瘤的一个预后指标。
Am J Hematol. 1989 Apr;30(4):195-200. doi: 10.1002/ajh.2830300402.
2
Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?流式细胞术检测的DNA含量亚二倍体在多发性骨髓瘤中具有预后价值吗?
Leuk Lymphoma. 1999 Sep;35(1-2):83-9. doi: 10.3109/10428199909145707.
3
A novel and easy FxCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six-color immunophenotyping.一种基于FxCycle™紫罗兰色染料的新型简易流式细胞术方法,用于同时评估DNA倍性和六色免疫表型分析。
Cytometry A. 2016 Mar;89(3):281-91. doi: 10.1002/cyto.a.22803. Epub 2015 Dec 15.
4
The flow-cytometric DNA content of the plasma cells of patients with multiple myeloma is a prognostic factor: a single institution experience.多发性骨髓瘤患者浆细胞的流式细胞术DNA含量是一个预后因素:单机构经验。
Hematology. 2010 Dec;15(6):378-81. doi: 10.1179/102453310X12719010991669.
5
Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients. Castelano-Leonés (Spain) Cooperative Group for the Study of Monoclonal Gammopathies.
Br J Haematol. 1995 May;90(1):106-12. doi: 10.1111/j.1365-2141.1995.tb03387.x.
6
Flow cytometric DNA analysis and clinical correlations in multiple myeloma.多发性骨髓瘤的流式细胞术DNA分析及临床相关性
Am J Clin Pathol. 1992 Mar;97(3):322-30. doi: 10.1093/ajcp/97.3.322.
7
DNA content of human myeloma cells.人骨髓瘤细胞的DNA含量
Eur J Cancer Clin Oncol. 1983 Jan;19(1):59-63. doi: 10.1016/0277-5379(83)90399-1.
8
S-phase cells of the lymphoplasmocytic compartment in hyperdiploid multiple myeloma are diploid cells.超二倍体多发性骨髓瘤中淋巴浆细胞区室的S期细胞为二倍体细胞。
Cytometry. 1995 Oct 1;21(2):203-10. doi: 10.1002/cyto.990210213.
9
Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.对免疫表型细胞进行流式细胞术DNA定量分析,作为一种灵敏方法用于测定治疗后外周血干细胞采集物和骨髓中的非整倍体多发性骨髓瘤细胞。
Bone Marrow Transplant. 1999 May;23(9):895-900. doi: 10.1038/sj.bmt.1701736.
10
Prognostic implications of tumor cell DNA and RNA content in multiple myeloma.
Blood. 1985 Aug;66(2):338-41.

引用本文的文献

1
Immunophenotypic Characterization and Ploidy Analysis of Neoplastic Plasma Cells by Multiparametric Flow Cytometry.多参数流式细胞术对肿瘤性浆细胞的免疫表型特征及倍体分析
Indian J Hematol Blood Transfus. 2022 Jul;38(3):473-480. doi: 10.1007/s12288-021-01477-y. Epub 2021 Aug 10.
2
Philadelphia-positive case negative for JAK2 V617F mutation with hyperdiploidic karyotype: A case report.费城染色体阳性但JAK2 V617F突变阴性且核型为超二倍体的病例:一例报告。
Mol Clin Oncol. 2019 Dec;11(6):607-611. doi: 10.3892/mco.2019.1933. Epub 2019 Oct 4.
3
Staging and prognostication of multiple myeloma.
多发性骨髓瘤的分期与预后评估
Expert Rev Hematol. 2014 Feb;7(1):21-31. doi: 10.1586/17474086.2014.882224.
4
A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.一个经过验证的荧光原位杂交三体指数显示了意义未明的单克隆丙种球蛋白病中的超二倍体和非超二倍体二分法。
Blood. 2005 Sep 15;106(6):2156-61. doi: 10.1182/blood-2005-02-0761. Epub 2005 May 26.
5
The prognostic role of the DNA ploidy pattern in colorectal cancer analysis using paraffin-embedded tissue by an improved method.采用改良方法对石蜡包埋组织进行结直肠癌分析时DNA倍体模式的预后作用。
Surg Today. 1994;24(1):30-6. doi: 10.1007/BF01676881.